Cynosure Announces Presentations at Upcoming Investor Conferences
June 02 2009 - 8:30AM
PR Newswire (US)
WESTFORD, Mass., June 2 /PRNewswire-FirstCall/ -- Cynosure, Inc.
(NASDAQ: CYNO), a leading developer and manufacturer of a broad
array of light-based aesthetic treatment systems, today announced
that President and Chief Executive Officer Michael Davin and Chief
Financial Officer Timothy Baker are scheduled to present at the
following investor conferences in New York City this month: --
Gabelli & Company Healthcare Symposium, Tuesday, June 9; the
presentation is scheduled to begin at 9:00 a.m. ET. -- Needham
& Co. 8th Annual Life Sciences Conference, Wednesday, June 10;
the presentation is scheduled to begin at 1:00 p.m. ET. --
Jefferies 3rd Annual Healthcare Conference, Thursday, June 18; the
presentation is scheduled to begin at 8:30 a.m. ET. Investors
interested in listening to the live webcasts of these presentations
should log on to the "Investor Relations" section of Cynosure's
website, http://www.cynosure.com/, and click on the link labeled
"Events." The presentations also will be archived on the company's
website. About Cynosure, Inc. Cynosure, Inc. develops and markets
aesthetic treatment systems that are used by physicians and other
practitioners to perform non-invasive and minimally invasive
procedures to remove hair, treat vascular and pigmented lesions,
rejuvenate the skin, liquefy and remove unwanted fat through laser
lipolysis and temporarily reduce the appearance of cellulite.
Cynosure's products include a broad range of laser and other
light-based energy sources, including Alexandrite, pulsed dye,
Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure
was founded in 1991. For corporate or product information, contact
Cynosure at 800-886-2966, or visit http://www.cynosure.com/.
Contact Scott Solomon Vice President Sharon Merrill Associates,
Inc. 617-542-5300 DATASOURCE: Cynosure, Inc. CONTACT: Scott
Solomon, Vice President of Sharon Merrill Associates, Inc.,
+1-617-542-5300, , for Cynosure, Inc. Web Site:
http://www.cynosure.com/
Copyright